Form 144 filing signals routine insider sale for tax or diversification purposes following restricted stock vesting. No material read-through for the stock; monitor for actual sale execution but expect no price impact.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 29 $8.69entry
- T+1 · 5mo ago −2.42%α −3.20% · $8.48
- T+5 · 4mo ago +6.90%α +5.52% · $9.29
- T+20 · 4mo ago +0.92%α +1.20% · $8.77
- T+60 · 8w ago −26.93%α −31.30% · $6.35
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Officer Bliss Kelly files Form 144 notice to sell 2,500 shares of Teladoc Health common stock valued at approximately $21,250. The shares were acquired via restricted stock vesting. The proposed sale is immaterial relative to the company's $1.5B market cap and follows recent insider selling activity.
Key Facts
- Insider Bliss Kelly (officer) intends to sell 2,500 shares of TDOC common stock.
- Estimated proceeds of ~$21,250 based on filing price (~$8.50/share).
- Shares acquired on 06/01/2025 via restricted stock vesting.
- Filing dated 2026-06-29; sale may occur before 08/29/2026.
- Recent 30-day insider activity includes 7 sells totaling $428K.
Financial Impact
Proceeds of ~$21,250 represent less than 0.001% of market cap. Negligible financial impact.
Risk Factors
- Insider may not complete the sale (Form 144 is notice of intent only).
- Small sale unlikely to indicate negative outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004939 |
| Document: 0001959173-26-004939-index.html | 0001959173-26-004939 |
| Document: 0001959173-26-004939.txt | 0001959173-26-004939 |
Track record
24 reports on TDOC
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +2.52% at T+1 after the Oct 28, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
- Nov 6, 202610d ago 144 Neutral 3/10 Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
- Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
- Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
- Oct 28, 202619d ago Press Release Bearish 6/10 No price data
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
- Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
- Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
- Sep 11, 20269w ago 144 Neutral 2/10 Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers